Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT
This study has been withdrawn prior to enrollment.
(Accrual issues - Low Accrual)
Sanjiv Sam Gambhir
First Posted: May 15, 2012
Last Update Posted: October 4, 2016
Information provided by (Responsible Party):
Sanjiv Sam Gambhir, Stanford University
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|